- Thrombotic microangiopathy2011 | Faculty of Medicine in Hradec Králové
- Thrombotic microangiopathy and pregnancy2020 | First Faculty of Medicine
- Thrombotic microangiopathies - hemolytic-uremic syndromes and thrombotic thrombocytopenic purpura2017 | Second Faculty of Medicine
- Analyses of data of patients with thrombotic microangiopathy in the WAA registry2011 | Faculty of Medicine in Hradec Králové
- Archiving of biological material collected in patients with acute attack of thrombotic microangiopathy2023 | Publication without faculty affiliation
- MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy2022 | Central Library of Charles University
- Influenza-associated thrombotic microangiopathies2018 | Second Faculty of Medicine
- Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study2023 | Second Faculty of Medicine
- Thrombotic microangiopathies in nephrology2020 | First Faculty of Medicine
- Thrombotic microangiopathies - availability of diagnostic methods and treatment options in the Czech Republic in 2021: results of a syndicated survey among clinical haematologists2023 | Publication without faculty affiliation
- Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Atypical haemolytic-uremic syndrome and new treatment options2014 | First Faculty of Medicine
- Eculizumab Treatment in atypical hemolytic uremic syndrome. Comment2013 | First Faculty of Medicine
- Atypical hemolytic uremic syndrome and current view on the treatment2017 | First Faculty of Medicine
- Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome2017 | First Faculty of Medicine
- Overlap of the symptoms of thrombotic thrombocytopenic purpura and antiphospholipid syndrome in a patient with juvenile systemic lupus erythematosus - case report2017 | Faculty of Medicine in Hradec Králové
- Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry2019 | First Faculty of Medicine
- Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis2020 | First Faculty of Medicine
- Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP2012 | Second Faculty of Medicine
- Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency2017 | First Faculty of Medicine
- Atypical hemolytic uremic syndrome in intensive care2017 | First Faculty of Medicine
- Hemolytic-uremic syndrome and new treatment options2013 | First Faculty of Medicine
- Hemolytic-uremic syndrome by children2020 | Second Faculty of Medicine
- Severe pulmonary hypertension as the first manifestation of gastric cancer in a young man2021 | First Faculty of Medicine
- Trombotic microangiopathy - a nephrologists' view2015 | First Faculty of Medicine
- Editorial: Urinary Tract Infections, Nephrotic Syndrome, Hemolytic Uremic Syndromes / Thrombotic Thrombocytopenic Purpura and Enuresis2017 | Second Faculty of Medicine
- Eculizumab treatment of child with hemolytic-uremic syndrome associated with Escherichia coli infection - case report2020 | Second Faculty of Medicine
- Proteinuria and Hypertension in Patients Treated with Inhibitors of the VEGF Signalling Pathway - Incidence, Mechanisms and Management2013 | First Faculty of Medicine